Irinotecan plus fluorouracil/folinic acid: increased risk of death?

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2001年 / 882卷 / 1期
关键词：
Fluorouracil; Irinotecan; Oxaliplatin; Leucovorin; Folinic Acid;
D O I：
10.2165/00128415-200108820-00010
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6 / 6
相关论文
共 50 条
  • [41] Efficacy of the association of folinic acid and 5-fluorouracil alone versus folinic acid and 5-fluorouracil plus 4-epidoxorubicin in the treatment of advanced gastric carcinoma
    Colucci, G
    Giotta, F
    Maiello, E
    Cifarelli, RA
    Leo, S
    Giuliani, F
    Pezzella, G
    Pedicini, A
    Valori, V
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (06): : 519 - 524
  • [42] Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (bFOLFIRINOX-3) in Chemorefractory Metastatic Colorectal Cancer
    Bellio, Helene
    Bertaut, Aurelie
    Hervieu, Alice
    Zanetta, Sylvie
    Hennequin, Audrey
    Vincent, Julie
    Palmier, Remi
    Bengrine-Lefevre, Leila
    Ghiringhelli, Francois
    Fumet, Jean-David
    CANCERS, 2021, 13 (21)
  • [43] Irinotecan combined with bolus 5-fluorouracil and folinic acid for metastatic colorectal cancer: Is this really a dangerous treatment?
    Idelevich, E
    Man, S
    Lavrenkov, K
    Gluzman, A
    Geffen, DB
    Shani, A
    JOURNAL OF CHEMOTHERAPY, 2004, 16 (05) : 487 - 490
  • [44] A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid
    Kieler, Markus
    Unseld, Matthias
    Bianconi, Daniela
    Scheithauer, Werner
    Prager, Gerald W.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [45] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Koehne, Claus-Henning
    Hofheinz, Ralf
    Mineur, Laurent
    Letocha, Henry
    Greil, Richard
    Thaler, Josef
    Fernebro, Eva
    Gamelin, Erick
    DeCosta, Lucy
    Karthaus, Meinolf
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (01) : 65 - 72
  • [46] A phase II study of mitomycin, fluorouracil, folinic acid, and irinotecan (MFI) for the treatment of transitional cell carcinoma of the bladder
    Bhattacharyya, Madhumita
    Powles, Tom
    Mutsvangwa, Katherine
    Wilson, Peter
    Oliver, Timothy
    Shamash, Jonathan
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (06) : 878 - 882
  • [47] Fluorouracil/folinic acid/oxaliplatinDiffuse alveolar damage: case report
    Reactions Weekly, 2009, 1280 (1) : 24 - 24
  • [48] RANDOMIZED PHASE-III STUDY OF 5-FLUOROURACIL PLUS HIGH-DOSE FOLINIC ACID VERSUS 5-FLUOROURACIL PLUS FOLINIC ACID PLUS METHYL-LOMUSTINE FOR PATIENTS WITH ADVANCED COLORECTAL-CANCER
    JONES, DV
    WINN, RJ
    BROWN, BW
    LEVY, LB
    PUGH, RP
    WADE, JL
    GROSS, HM
    PENDERGRASS, KB
    LEVIN, B
    ABBRUZZESE, JL
    CANCER, 1995, 76 (10) : 1709 - 1714
  • [49] Fluorouracil/folinic acid/oxaliplatinFatal pulmonary fibrosis: case report
    Reactions Weekly, 2008, 1207 (1) : 20 - 20
  • [50] Weekly treatment with irinotecan, folinic acid and infusional 5-fluorouracil (ILF) in patients with advanced gastric cancer
    Moehler, M
    Haas, U
    Siebler, J
    Schimanski, C
    Hertkorn, C
    Hoehler, T
    Galle, PR
    Heike, M
    ANTI-CANCER DRUGS, 2003, 14 (08) : 645 - 650
12345